Spruce Biosciences Inc.(SPRB)
Rare disease drug company
1 Insight
Investment Insights
AI-generated insights about Spruce Biosciences Inc. from various financial sources
Wednesday, October 22, 2025
Very Bullish
Target: 5x current price
The speaker is bullish, viewing it as a long-term investment with a drug that 'works really well' and is likely to receive FDA approval, potentially leading to a 5x return.
Wednesday, October 22, 2025
Very Bullish
Target: 5x current price
The speaker is bullish, viewing it as a long-term investment with a drug that 'works really well' and is likely to receive FDA approval, potentially leading to a 5x return.